tirzepatide weight loss clinic in katy tx Houston, & Mounjaro for Struggling to Wake Up and
Description
This course is for nurse practitioners and advanced practice providers who want to use GLP-1 receptor agonists at sub-therapeutic doses as a precision metabolic and longevity tool either in an existing cash-based wellness practice or as a new service line
FDA approval is expected in 2027 or 2028
These symptoms typically improve within 4-8 weeks as the body adjusts to treatment
The street price is now a competitor
